biological_process

INFLAMMASOME

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about INFLAMMASOME: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1928Connections

24Hypotheses

0Analyses

50Outgoing

50Incoming

10Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

🧬 Biological Process Info

Name	INFLAMMASOME
Key Genes/Proteins	ABCA1, ACHE, AD, AKT, AMPK, AMYLOID-BETA
Related Diseases	Alzheimer's Disease, ALZHEIMER'S DISEASE, ANXIETY
Related Pathways	APOPTOSIS

Pathway Diagram

graph TD
    INFLAMMASOME["Inflammasome"]
    NLRP3["NLRP3"]
    PYCARD["PYCARD/ASC"]
    MICROGLIA["Microglia"]
    INFLAMMATION["Inflammation"]
    TNF["TNF-alpha"]
    IL1B["IL-1beta"]
    NEURODEGENERATION["Neurodegeneration"]
    PARKINSON["Parkinson's Disease"]
    MULTIPLE_SCLEROSIS["Multiple Sclerosis"]
    SNCA["alpha-synuclein (SNCA)"]
    PARKIN["Parkin"]
    AUTOPHAGY["Autophagy"]
    UBIQUITIN["Ubiquitin System"]

    NLRP3 -->|"forms"| INFLAMMASOME
    PYCARD -->|"assembles"| INFLAMMASOME
    INFLAMMASOME -->|"activates"| MICROGLIA
    INFLAMMASOME -->|"triggers"| INFLAMMATION
    INFLAMMASOME -->|"releases"| TNF
    INFLAMMASOME -->|"releases"| IL1B
    INFLAMMATION -->|"promotes"| NEURODEGENERATION
    MICROGLIA -->|"amplifies"| INFLAMMATION
    SNCA -->|"activates"| INFLAMMASOME
    NEURODEGENERATION -->|"leads to"| PARKINSON
    NEURODEGENERATION -->|"contributes to"| MULTIPLE_SCLEROSIS
    INFLAMMASOME -->|"impairs"| AUTOPHAGY
    PARKIN -->|"regulates"| AUTOPHAGY
    AUTOPHAGY -->|"clears"| SNCA
    INFLAMMASOME -->|"activates"| UBIQUITIN

    style INFLAMMASOME fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0
    style AUTOPHAGY fill:#1b5e20,stroke:#333,stroke-width:2px
    style PARKIN fill:#1b5e20,stroke:#333,stroke-width:2px
    style NEURODEGENERATION fill:#ef5350,stroke:#333,stroke-width:2px
    style INFLAMMATION fill:#ef5350,stroke:#333,stroke-width:2px
    style PARKINSON fill:#7d4200,stroke:#333,stroke-width:2px
    style MULTIPLE_SCLEROSIS fill:#7d4200,stroke:#333,stroke-width:2px
    style NLRP3 fill:#4a1a6b,stroke:#333,stroke-width:2px
    style SNCA fill:#4a1a6b,stroke:#333,stroke-width:2px
    style TNF fill:#4a1a6b,stroke:#333,stroke-width:2px

Outgoing (428)

Target	Relation	Type	Str
ALZHEIMER'S DISEASE	associated_with	disease	0.95
Oxidative Phosphorylation	downregulates	pathway	0.95
PARKINSON'S DISEASE	contributes_to	disease	0.95
M1 Polarization	causes	phenotype	0.95
ALS	contributes_to	disease	0.95
Microglia	activates	cell_type	0.95
Neurodegeneration	promotes	process	0.95
Glycolysis	upregulates	pathway	0.95
Neuroinflammation	activates	process	0.95
Microglial M1 Polarization	causes	phenotype	0.95
DEMENTIA	contributes_to	disease	0.92
Dopaminergic Neurodegeneration	mediates	process	0.90
Misfolded Protein Aggregation	associated_with	process	0.90
Metabolic Reprogramming	causes	process	0.90
NEUROINFLAMMATION	mediates	process	0.89
Protein Aggregation	associated_with	process	0.88
M1 Polarization	causes	phenotype	0.88
MICROGLIA	interacts_with	cell_type	0.86
AUTOPHAGY	activates	process	0.86
Multiple Sclerosis	involved_in	disease	0.85
Parkinson's Disease	involved_in	disease	0.85
Alzheimer's Disease	involved_in	disease	0.85
Oxidative Phosphorylation	inhibits	process	0.85
Alzheimer Disease	associated_with	disease	0.85
organ fibrosis	drives	disease	0.85
Parkinson Disease	associated_with	disease	0.85
pyroptosis	activates	phenotype	0.64
MMP9	expresses	gene	0.60
OXIDATIVE STRESS	associated_with	pathway	0.60
VCP	expresses	gene	0.60
STAT3	associated_with	gene	0.60
ULK1	activates	gene	0.60
OXIDATIVE STRESS	causes	pathway	0.60
MACROPHAGE	expresses	cell_type	0.60
NECROPTOSIS	regulates	pathway	0.60
STING	causes	gene	0.60
PD	causes	gene	0.60
MACROPHAGE	mediates	cell_type	0.60
TLR4	associated_with	gene	0.60
TRAF6	activates	gene	0.60
PYROPTOSIS	expresses	pathway	0.60
MLKL	interacts_with	gene	0.60
JAK	regulates	gene	0.60
NLRP3	degrades	gene	0.60
TLR4	enhances	gene	0.60
MAPK	co_discussed	gene	0.60
MLKL	activates	gene	0.60
NECROPTOSIS	interacts_with	pathway	0.60
NLRP3	inhibits	gene	0.60
MICROGLIA	causes	cell_type	0.60

Incoming (1500)

Source	Relation	Type	Str
DNA	activates	gene	1.00
ALZHEIMER	activates	gene	1.00
INFLAMMATION	associated_with	gene	1.00
Inflammation	associated_with	disease	1.00
INFLAMMATION	regulates	gene	1.00
UBIQUITIN	activates	gene	1.00
NEUROINFLAMMATION	activates	gene	1.00
Als	therapeutic_target	disease	1.00
MICROGLIA	activates	gene	1.00
MITOCHONDRIA	activates	gene	1.00
AIM2	activates	gene	1.00
INFLAMMATION	activates	gene	1.00
AUTOPHAGY	activates	gene	1.00
Atherosclerosis	activates	disease	1.00
Alzheimer	activates	disease	1.00
INFLAMMATION	inhibits	gene	1.00
Inflammation	activates	disease	1.00
OXIDATIVE STRESS	activates	gene	1.00
Infection	activates	disease	1.00
NLRP3	activates	gene	1.00
MITOCHONDRIAL DYSFUNCTION	activates	gene	1.00
CYTOKINES	activates	gene	1.00
APOPTOSIS	activates	gene	1.00
TNF	activates	gene	1.00
NLRP3	regulates	gene	1.00
NEURODEGENERATIVE DISEASES	activates	gene	1.00
MITOPHAGY	activates	gene	1.00
ASC	activates	gene	1.00
PYROPTOSIS	activates	gene	1.00
Als	regulates	disease	1.00
Inflammation	regulates	disease	1.00
ROS	activates	gene	1.00
Inflammation	inhibits	disease	1.00
AUTOPHAGY	regulates	gene	1.00
Aging	activates	disease	1.00
IL-6	inhibits	gene	1.00
Neuroinflammation	activates	disease	1.00
NLRP3	inhibits	gene	1.00
ALZHEIMER'S DISEASE	activates	gene	1.00
Als	activates	disease	1.00
NF-ΚB	activates	gene	1.00
NEURODEGENERATION	activates	gene	1.00
CANCER	activates	gene	1.00
PARKIN	activates	gene	1.00
IL-6	activates	gene	1.00
PINK1	activates	gene	1.00
Cancer	activates	disease	1.00
Neurodegeneration	activates	disease	1.00
AMYLOID	activates	gene	1.00
NLRP3	involved_in	protein	0.95

Targeting Hypotheses (24)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43	0.824	neurodegeneration	What are the mechanisms by which gut mic
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S	0.822	neurodegeneration	What are the mechanisms by which gut mic
Mitochondrial DAMPs-Driven AIM2 Inflammasome Activation in N	0.805	neurodegeneration	What are the mechanisms by which gut mic
Calcium-Dysregulated mPTP Opening as an Alternative mtDNA Re	0.804	neurodegeneration	What are the mechanisms by which gut mic
Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neu	0.803	neurodegeneration	What are the mechanisms by which gut mic

NLRP3 Inflammasome Lock Perpetuates Senescence-Associated In	0.720	neurodegeneration	What molecular mechanisms drive microgli
TREM2 haploinsufficiency dysregulates microglial synaptic su	0.700	neurodegeneration	Synaptic pruning by microglia in neurode
Microbial Inflammasome Priming Prevention	0.653	neurodegeneration	What are the mechanisms by which gut mic
C1Q-Triggered NLRP3 Inflammasome Assembly in Plaque Macropha	0.631	neuroinflammation	What are the specific molecular mechanis
Galectin-3 deletion attenuates NLRP3 inflammasome activation	0.625	neuroscience	Lysosomal dysfunction and cathepsin leak
NLRP3 Inflammasome Priming Converts SCFA-Sensitive Pyroptosi	0.620	neurodegeneration	How does gut microbiome dysbiosis contri
Selective cathepsin B inhibition prevents cathepsin leakage-	0.620	neuroscience	Lysosomal dysfunction and cathepsin leak
LRP1/NLRP3/IL-1β Cascade Links Aβ Endocytosis to Inflammasom	0.617	neurodegeneration	How do perivascular cells specifically r
Intermittent HBOT (2.0 ATA, 60 min, 3x/week) suppresses NLRP	0.590	neurodegeneration	What are the optimal oxygen pressure, du
NLRP3 Inflammasome Chromatin Priming Through H3K27ac Accumul	0.566	developmental neurobiology	Do perinatal immune challenges create pe
NLRP3 Inflammasome Blockade as Upstream Intervention to Prev	0.566	neurodegeneration	Why have numerous phase 3 clinical trial
P2X7R PET Imaging for NLRP3 Inflammasome-Associated Priming	0.563	biomarkers	What biomarkers can reliably detect micr
TFEB-Mediated Lysosomal Biogenesis Enhancement for NLRP3 Inf	0.485	Neuroinflammation	Immune atlas neuroinflammation analysis
Sub-antidepressant Doses Suppress NLRP3 Inflammasome via P2X	0.465	-	What is the minimum effective dose of tr
Mitochondrial Damage-Triggered SPP1 Inflammasome Coupling	0.453	neuroinflammation	What molecular mechanisms mediate SPP1-i
microglial inflammasome tone defines the therapeutic window	0.341	neurodegeneration	How does gut microbiome dysbiosis contri
NLRP3 Inflammasome Suppression via Selective Caspase-1 Inhib	0.105	neurodegeneration	Neuroinflammation Biomarker Panel for Ea
STING-Mediated NLRP3 Inflammasome Priming in ALS Microglia	0.000	Neuroinflammation	Immune atlas neuroinflammation analysis
Circulating hs-CRP as Disease-Modifying Target via Astrocyti	0.000	immunomics	Systemic immune profiling in neurodegene

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (10)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phe	clinical	Neurodegeneration	0.400	0.50	in_silico	proposed	$180,000
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiation Mechanis	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk Cohorts	clinical	ALS	0.400	0.50	human	proposed	$6,550,000
Antiviral Therapy Trial for Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Experiment: Autoimmune Hypothesis Testing in AD	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
cGAS-STING Pathway Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$7,100,000
Microbiome-Gut Barrier Signatures in ALS — Experiment Design	clinical	ALS	0.400	0.50	human	proposed	$6,550,000
Microbiome-Gut-Brain Axis in Alzheimer's Disease — mechanism and inter	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,500,000
NLRP3 Inflammasome Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Regulated Necrosis Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Systemic inflammation as a central player in the initiation and development of A [PMID:40841660]	Bayraktaroglu I, Ortí-Casañ N, Van Dam D	Immunity & ageing : I & A	2025	1
USP22 suppresses the NLRP3 inflammasome by degrading NLRP3 via ATG5-dependent au [PMID:35900990]	["Di Q", "Zhao X", "Tang H", "Li X", "Xi	Autophagy	2023	1
USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradatio [PMID:34486483]	["Cai B", "Zhao J", "Zhang Y", "Liu Y",	Autophagy	2022	1
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861]	["Han X", "Sun S", "Sun Y", "Song Q", "Z	Autophagy	2020	1
Interweaving microglial senescence and gut microbiome dynamics in Alzheimer's di [PMID:41747877]	Waghmare A, Rahangdale S, Khare K, Taksa	Molecular and cellular neurosc	2026	0
The Immuno-Glial Connectome in Alzheimer's Disease: Integrating Central and Peri [PMID:41569436]	Gopalakrishna PK, Che Mohd Nassir CMN, A	Cellular and molecular neurobi	2026	0
Elevated expression of the NLRP3 inflammasome in post-mortem brain white matter [PMID:41687275]	Otálora-Alcaraz A, Sun MC, Hofman N, Cos	Multiple sclerosis and related	2026	0
NLRP3 Inflammasome and Polycystic Ovary Syndrome (PCOS): A Novel Profile in Adip [PMID:41596350]	Alenezi SA, Alshammari K, Khan R, Amer S	International journal of molec	2026	0
Exploring the Role of Microglial Cells in the Gut-Brain Axis Communication: A Sy [PMID:40662222]	Ortiz-Samur NS, Vijaya AK, Burokas A, Me	Journal of neurochemistry	2025	0
Sepsis and the Liver. [PMID:41439929]	["Geladari E", "Kalergi A", "Evangelopou	Diseases (Basel, Switzerland)	2025	0
Nlrc4 Inflammasome Expression After Acute Myocardial Infarction in Rats. [PMID:40332346]	Borim PA, Gatto M, Mota GAF, Meirelles A	Int J Mol Sci	2025	0
Molecular links between inflammatory bowel disease and Alzheimer's disease throu [PMID:41480321]	Durairajan SSK, Singh AK, Sulaiman SM, P	World journal of gastroenterol	2025	0
Bone marrow vacuolization to curative strategies: Evolving paradigms in VEXAS sy [PMID:40784090]	["Elbadry M", "Mabed M"]	Current research in translatio	2025	0
Δ9-Tetrahydrocannabinol and cannabidiol selectively suppress toll-like receptor [PMID:40553974]	Sermet S, Finn BM, Crawford RB, Kaminski	The Journal of pharmacology an	2025	0
Nlrc4 Inflammasome Expression After Acute Myocardial Infarction in Rats. [PMID:40332346]	Borim PA, Gatto M, Mota GAF, Meirelles A	International journal of molec	2025	0
The NLRP3-inflammasome inhibitor MCC950 improves cardiac function in a HFpEF mou [PMID:39616735]	["Li S", "Withaar C", "Rodrigues P", "Zi	Biomedicine & pharmacotherapy	2024	0
Andrographolide Attenuates NLRP3 Inflammasome Activation and Airway Inflammation [PMID:38808326]	Yu Y, Miao TW, Xiao W, Mao B, Du LY, Wan	Drug design, development and t	2024	0
Inhibition of autophagy in microglia and macrophages exacerbates innate immune r [PMID:36652438]	Hegdekar N, Sarkar C, Bustos S, Ritzel R	Autophagy	2023	0
Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's [PMID:37029500]	Yan YQ, Zheng R, Liu Y, Ruan Y, Lin ZH,	Aging cell	2023	0
Inflammasome assembly in neurodegenerative diseases. [PMID:37633753]	Singh J, Habean ML, Panicker N	Trends in neurosciences	2023	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning INFLAMMASOME in their description or question text

NLRP3 Inflammasome Lock Perpetuates Senescence-Associated Inflammasome Phenotype

Score: 0.720 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The NLRP3 (NACHT, LRR and PYD domains-containing protein 3) inflammasome represen

TREM2 haploinsufficiency dysregulates microglial synaptic surveillance, switchin

Score: 0.700 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The triggering receptor expressed on myeloid cells 2 (TREM2) functions as a criti

Microbial Inflammasome Priming Prevention

Score: 0.653 · neurodegeneration · 2026-04-02

Pathogenic gut bacteria prime peripheral macrophages through NLRP3 inflammasome activation, creating a systemic pro-infl

C1Q-Triggered NLRP3 Inflammasome Assembly in Plaque Macrophages

Score: 0.631 · neuroinflammation · 2026-04-21

**Molecular Mechanism and Rationale** The C1Q complement system component represents a critical bridge between innate i

Galectin-3 deletion attenuates NLRP3 inflammasome activation downstream of lysos

Score: 0.625 · neuroscience · 2026-04-22

**Molecular Mechanism and Rationale** Galectin-3 (LGALS3) functions as a critical molecular sensor and platform orchest

NLRP3 Inflammasome Priming Converts SCFA-Sensitive Pyroptosis into Chronic IL-1β

Score: 0.620 · neurodegeneration · 2026-04-26

Gut-derived bacterial components (LPS, MDP) provide Signal 1 for NLRP3 inflammasome priming via TLR4/TLR2/NOD2, inducing

Selective cathepsin B inhibition prevents cathepsin leakage-mediated NLRP3 infla

Score: 0.620 · neuroscience · 2026-04-22

## Mechanistic Overview Selective cathepsin B inhibition prevents cathepsin leakage-mediated NLRP3 inflammasome activati

LRP1/NLRP3/IL-1β Cascade Links Aβ Endocytosis to Inflammasome Activation and SPP

Score: 0.617 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The proposed LRP1/NLRP3/IL-1β cascade represents a critical mechanistic link betw

Intermittent HBOT (2.0 ATA, 60 min, 3x/week) suppresses NLRP3 inflammasome and s

Score: 0.590 · neurodegeneration · 2026-04-25

This hypothesis proposes that HBOT reduces ROS-mediated NF-κB activation and NLRP3 inflammasome assembly, promoting anti

NLRP3 Inflammasome Chromatin Priming Through H3K27ac Accumulation

Score: 0.566 · developmental neurobiology · 2026-04-21

## Mechanistic Overview NLRP3 Inflammasome Chromatin Priming Through H3K27ac Accumulation starts from the claim that mod

NLRP3 Inflammasome Blockade as Upstream Intervention to Prevent SASP Amplificati

Score: 0.566 · neurodegeneration · 2026-04-16

## Mechanistic Overview NLRP3 Inflammasome Blockade as Upstream Intervention to Prevent SASP Amplification starts from t

P2X7R PET Imaging for NLRP3 Inflammasome-Associated Priming

Score: 0.563 · biomarkers · 2026-04-22

## Mechanistic Overview P2X7R PET Imaging for NLRP3 Inflammasome-Associated Priming starts from the claim that modulatin

TFEB-Mediated Lysosomal Biogenesis Enhancement for NLRP3 Inflammasome Regulation

Score: 0.485 · Neuroinflammation · 2026-04-21

## Mechanistic Overview TFEB-Mediated Lysosomal Biogenesis Enhancement for NLRP3 Inflammasome Regulation starts from the

Sub-antidepressant Doses Suppress NLRP3 Inflammasome via P2X7 Receptor Blockade

Score: 0.465 · unknown disease · 2026-04-26

Trazodone acts as a weak antagonist at P2X7 purinergic receptors (IC50 ~3 micromolar), suppressing microglial NLRP3 infl

Mitochondrial Damage-Triggered SPP1 Inflammasome Coupling

Score: 0.453 · neuroinflammation · 2026-04-21

## Mechanistic Overview Mitochondrial Damage-Triggered SPP1 Inflammasome Coupling starts from the claim that modulating